AstraZeneca PLC (AZN)
NYSE: AZN · Real-Time Price · USD
189.28
+5.40 (2.94%)
Nov 4, 2026, 3:23 PM EST - Market open
AstraZeneca Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 301,493 | 287,813 | 203,171 | 209,268 | 209,442 | 182,034 | |
Market Cap Growth | 18.03% | 41.66% | -2.91% | -0.08% | 15.06% | 38.68% |
Enterprise Value | 328,111 | 312,406 | 228,175 | 234,801 | 238,391 | 209,520 |
Last Close Price | 183.88 | 172.53 | 125.08 | 128.55 | 130.24 | 110.76 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 26.44 | 28.15 | 28.88 | 35.14 | 63.70 | 1625.31 |
PS Ratio | 4.69 | 4.90 | 3.76 | 4.57 | 4.72 | 4.87 |
PB Ratio | 5.65 | 5.91 | 4.97 | 5.34 | 5.65 | 4.63 |
P/FCF Ratio | 28.69 | 24.46 | 20.45 | 23.29 | 24.03 | 37.36 |
P/OCF Ratio | 22.14 | 19.75 | 17.13 | 20.23 | 21.35 | 30.53 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 5.12 | 5.32 | 4.22 | 5.13 | 5.38 | 5.60 |
EV/EBITDA Ratio | 15.01 | 16.20 | 12.99 | 16.45 | 17.35 | 31.27 |
EV/EBIT Ratio | 19.85 | 21.86 | 17.65 | 24.21 | 27.05 | 72.32 |
EV/FCF Ratio | 31.29 | 26.55 | 22.96 | 26.14 | 27.35 | 43.01 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.66 | 0.61 | 0.75 | 0.76 | 0.84 | 0.85 |
Debt / EBITDA Ratio | 1.58 | 1.51 | 1.70 | 2.04 | 2.23 | 4.81 |
Debt / FCF Ratio | 3.36 | 2.53 | 3.07 | 3.30 | 3.57 | 6.85 |
Net Debt / Equity Ratio | 0.51 | 0.49 | 0.61 | 0.61 | 0.67 | 0.69 |
Net Debt / EBITDA Ratio | 1.23 | 1.24 | 1.42 | 1.67 | 1.81 | 4.02 |
Net Debt / FCF Ratio | 2.56 | 2.04 | 2.51 | 2.65 | 2.86 | 5.54 |
Asset Turnover | 0.53 | 0.54 | 0.53 | 0.46 | 0.44 | 0.44 |
Inventory Turnover | 1.69 | 1.81 | 1.80 | 1.59 | 1.26 | 1.85 |
Quick Ratio | 0.79 | 0.65 | 0.67 | 0.58 | 0.62 | 0.67 |
Current Ratio | 1.01 | 0.94 | 0.93 | 0.82 | 0.86 | 1.16 |
Return on Equity (ROE) | 22.57% | 22.84% | 17.59% | 15.64% | 8.63% | 0.42% |
Return on Assets (ROA) | 8.58% | 8.19% | 7.88% | 6.13% | 5.46% | 2.10% |
Return on Invested Capital (ROIC) | 17.15% | 17.03% | 16.27% | 13.42% | 13.75% | 6.00% |
Return on Capital Employed (ROCE) | 18.20% | 17.10% | 17.00% | 13.70% | 12.60% | 3.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.78% | 3.55% | 3.46% | 2.85% | 1.57% | 0.06% |
FCF Yield | 3.49% | 4.09% | 4.89% | 4.29% | 4.16% | 2.68% |
Dividend Yield | 1.71% | 1.72% | 2.37% | 2.15% | 2.15% | 2.44% |
Payout Ratio | 45.25% | 47.39% | 65.47% | 75.42% | 132.72% | 3442.86% |
Buyback Yield / Dilution | 0.02% | 0.06% | -0.06% | -0.13% | -9.32% | -8.68% |
Total Shareholder Return | 1.73% | 1.79% | 2.30% | 2.02% | -7.17% | -6.24% |